Marc Hasenfuss Editor-at-large

The markets have been awfully tricky to traverse in 2016, but jittery investment sentiment did nothing to stanch deal flows during the year. Aside from the "gorilla deal" of SABMiller being acquired by Anheuser-Busch InBev, there were a good number of other smaller, but significant, transactions that would have kept corporate advisory fees ticking over nicely. These included Mediclinic International’s reverse takeover of Al Noor Hospital Group, a property deal between gaming and hotel group Tsogo Sun and Hospitality, the Blue Label Telecoms tilt at a major stake in Cell C, HCI’s sale of KWV’s operating assets to Vasari, empowerment group Brimstone’s topping up of its shareholding in Sea Harvest (which in turn took on strong Australian flavours), enX’s buyout of Eqstra, health-care conglomerate Ascendis’s clinching of two sizeable offshore acquisitions, Stellar Capital Partners’ purchase of Prescient and the securing by Amecor and Country Bird Holdings of a negative control block in ...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now